| Literature DB >> 29353420 |
Łukasz Jałowiecki1, Joanna Żur2, Joanna Chojniak3, Helene Ejhed4, Grażyna Płaza3.
Abstract
The aim of the present study was to determine some properties of antibiotic-resistant bacterial strains isolated from onsite wastewater technology in relation to biofilm formation, e.g., autoaggregation and motility. Additionally, biosurfactant production by the isolates was also evaluated. The ability of selected strains to develop a biofilm was assessed by using the crystal violet method, which allows to indirectly quantify the attached bacterial biomass (live, dead cells, and polysaccharides as well). Obtained results showed that 19 of the analyzed strains were able to produce biofilm after 72 h of incubation. The low values of surface tension in the range between 28 and 36 mN/m were observed in the bacteria, which are not able to produce biofilm or be classified as weak biofilm producers. Among biofilm-forming strains the highest autoaggregation index was observed for Mycobacterium brumae and Bacillus alcalophilus. Noteworthy, that some strains capable of biofilm formation showed no aggregation abilities or were characterized by low autoaggregative properties. The results of visual autoaggregation assay showed no visible flocs after given time of incubation. The results from motility test demonstrated that most of the analyzed strains were motile. Noteworthy, that up to now literature data about physiology, biofilm formation, and autoaggregative capabilities of bacteria isolated from onsite wastewater technology are very limited and this paper gives the information on the antibiotic-resistant bacteria with ability to form biofilm. Thus, the present study points to develop novel bioinocula in antibiotic degradation and to reach novel biofilm-dispersing agents produced by various bacteria that can be used as disinfectants or surface-coating agents to prevent microbial surface colonization and biofilm development.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29353420 PMCID: PMC5884911 DOI: 10.1007/s00284-017-1428-2
Source DB: PubMed Journal: Curr Microbiol ISSN: 0343-8651 Impact factor: 2.188
List of antibiotics used in this study
| Active substance | Symbol | Level (µg) | Group | Effects |
|---|---|---|---|---|
| Amikacin | AK | 30 | Aminoglycosides | Protein synthesis disruption/binding to the 30S-subunit of ribosome |
| Amoxicillin | AML | 30 | Aminopenicillins | Binding to penicillin-binding protein 1A (PBP-1A) inside the bacterial cell well |
| Ampicillin | AMP | 25 | Aminopenicillins | Inhibition of bacterial cell wall synthesis/interferes with autolysin inhibitor |
| Azithromycin | AZM | 15 | macrolides | Protein synthesis inhibition/binding to the 50S ribosomal subunit of the bacterial 70S ribosome |
| Aztreonam | ATM | 30 | Beta-lactams/ | Inhibition of bacterial cell wall synthesis/high affinity for penicillin-binding protein 3 (PBP3) |
| Cefaclor | CEC | 30 | Cephalosporins | Binding to penicillin-binding proteins (PBPs) inside the bacterial cell wall |
| Cefadroxil | CFR | 30 | Cephalosporins | Binding to specific penicillin-binding proteins (PBPs) inside the bacterial cell wall |
| Cefoxitin | FOX | 30 | Cephalosporins | Inhibition of cell wall synthesis |
| Ceftaroline | CPT | 5 | Cephalosporins | Inhibition of cell wall synthesis |
| Ceftazidime | CAZ | 30 | Cephalosporins | Binding to specific penicillin-binding proteins (PBPs) inside the bacterial cell wall |
| Ciprofloxacin | CIP | 10 | Chemotherapeutic | Inhibition of the topoisomerase II (gyrase) and topoisomerase IV, required for DNA replication, recombination, transcription, and strand supercoiling repair |
| Doripenem | DOR | 10 | Carbapenems | Inhibition of penicillin-binding proteins (PBPs), mostly 1a, 1b, 2, 3 |
| Doxycycline | DO | 30 | Tetracycline | Reversibly binds to the 30 S ribosomal subunits, blocking the binding of aminoacyl-tRNA to the mRNA/ inhibiting bacterial protein synthesis |
| Ertapenem | ETP | 10 | Carbapenems | Binding to penicillin-binding proteins (PBPs) |
| Erythromycin | E | 30 | Macrolides | Reversibly binding to the 50S subunit of bacterial ribosomes |
| Gentamicin | CN | 120 | Aminoglycosides | Bind to 30S-subunit proteins and 16S rRNA |
| Imipenem | IPM | 10 | Carbapenems | Inhibition of cell wall synthesis/binding to penicillin-binding proteins (PBPs) |
| Metronidazole | MTZ | 50 | Chemotherapeutic | Prodrug/disruption of DNA helical structure/inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death |
| Minocycline | MH | 30 | Tetracycline | Binding to the 30S ribosomal subunit/preventing the binding of tRNA to the mRNA-ribosome/interfering with protein synthesis |
| Mupirocin | MUP | 200 | Mupirocin | Inhibition of bacterial protein and RNA synthesis/reversibly binds to bacterial isoleucyl-tRNA synthetase |
| Nalidixic acid | NA | 30 | Chemotherapeutic | Binding reversibly to DNA/interfering with synthesis of RNA and proteins |
| Neomycin | N | 10 | Aminoglycosides | Binding to specific 30S subunit proteins and 16S rRNA |
| Netilmicin | NET | 30 | Aminoglycosides | Irreversibly bind to specific 30S subunit proteins and 16S rRNA |
| Nitrofurantoin | F | 300 | Chemotherapeutic | Activated by nitrofuran reductase/inhibition of DNA, RNA, protein, and cell wall synthesis |
| Norfloxacin | NOR | 10 | Chemotherapeutic | Inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV |
| Novobiocin | NV | 30 | Aminoglycosides | Aminocoumarin/inhibition of bacterial DNA gyrase/competitive inhibitors of the ATPase reaction catalyzed by GyrB |
| Ofloxacin | OFX | 5 | Chemotherapeutic | Acts on DNA gyrase and topoisomerase IV/inhibiting cell division |
| Piperacillin | PRL | 100 | Penicillin | Binding to specific penicillin-binding proteins (PBPs) inside the bacterial cell wall |
| Rifampicin | RD | 30 | Rifampicin | Inhibition of DNA-dependent RNA polymerase/suppression of RNA synthesis and cell death |
| Teicoplanin | TEC | 30 | Peptide | Inhibition of peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death |
| Ticarcillin | TIC | 75 | Penicillin | Able to prevent cross-linking of peptidoglycan during cell wall synthesis |
| Tobramycin | TOB | 30 | Aminoglycosides | Binding irreversibly to one of two aminoglycoside-binding sites on the 30S ribosomal subunit/inhibiting bacterial protein synthesis |
| Trimethoprim | W | 5 | Chemotherapeutic | Binding to dihydrofolate reductase/inhibition of the reduction of dihydrofolic acid (DHF) to tetrahydrofolic acid (THF) |
| Trimethoprim- sulfamethoxazole | SXT | 25 | Chemotherapeutic | Inhibition of the enzymatic conversion of pteridine and p-aminobenzoic acid (PABA) to dihydropteroic acid by competing with PABA for binding to dihydrofolate synthetase |
| Vancomycin | VA | 30 | Peptide | Inhibition of cell wall biosynthesis |
Resistance of the bacteria to selected antibiotics
| Species | Antibiotics | |
|---|---|---|
| Number | Symbol | |
|
| 4 | ATM,CEC,CAZ,MTZ |
|
| 2 | NA,MTZ |
|
| 3 | DOR,ETP,MTZ |
|
| 21 | AML,AMP,ATM,CEC,CFR,FOX,CPT,CAZ,DOR,ETP,IPM,MTZ,MUP,NA,N,F,NV,PRL,RD,TEC,W |
|
| 20 | AK,AML,AMP,CEC,CFR,FOX,CPT,CAZ,DOR,ETP,IPM,MTZ,MUP,N,F,NV,PRL,RD,TEC,SXT |
|
| 9 | AMP,ATM,CPT,CAZ,MTZ,MUP,RD,W,SXT |
|
| 2 | MTZ,TIC |
|
| 8 | AMP,ATM,CPT,CAZ,MTZ,MUP,RD,W |
|
| 7 | ATM,CAZ,MTZ,PRL,RD,TEC,W |
|
| 9 | CAZ,MTZ,F,NV,PRL,TEC,TIC,W,VA |
|
| 1 | E |
|
| 1 | MTZ |
| 6 | ATM,CFR,CAZ,MTZ,W,SXT | |
|
| 1 | MTZ |
|
| 1 | MTZ |
|
| 1 | MTZ |
|
| 2 | PRL,TEC |
|
| 1 | MTZ |
|
| 1 | MTZ |
|
| 1 | MTZ |
|
| 10 | AML,AMP,ATM,CPT,CAZ,MTZ,MUP,RD,W,SXT |
|
| 10 | AMP,CFR,DOR,ETP,IPM,MTZ,NA,NV,PRL,TEC |
|
| 2 | MTZ,NA |
|
| 35 | AK,AML,AMP,AZM,ATM,CEC,CFR,FOX,CPT,CAZ,CIP,DOR,DO,ETP,E,CN,IPM,MTZ,MH,MUP,NA,N,NET,F,NOR,NV,OFX,PRL,RD,TEC,TIC,TOB,W,SXT,VA |
|
| 4 | MTZ,TEC,W,VA |
|
| 7 | AMP,CAZ,,MTZ,F,TEC,W,VA |
|
| 4 | MTZ,TEC,W,VA |
|
| 1 | MTZ |
|
| 17 | AK,AML,AMP,ATM,CPT,E,IPM,MTZ,MUP,N,F,PRL,TEC,TOB,W,SXT,VA |
|
| 11 | AML,AMP,CEC,CFR,DO,MTZ,F,NV,RD,TEC,VA |
Relation between biofilm formation and surface activity (Mean ± Stand. Dev.)
| Species | Properties | |||
|---|---|---|---|---|
| Biofilm (600 nm) | Surface tension (mN/m) | |||
| 24 h | 48 h | 72 h | 72 h | |
|
| 0.00 | 0.06 ± 0.05 | 0.10 ± 0.03 | 36.35 ± 0.08 |
|
| 0.00 | 0.09 ± 0.001 | 0.00 | 32.96 ± 0.04 |
|
| 0.00 | 0.00 | 0.00 | 32.15 ± 0.12 |
| 0.00 | 1.36 ± 0.13 | 1.27 ± 0.02 | 56.77 ± 0.10 | |
| 1.76 ± 0.09 | 1.23 ± 0.13 | 0.89 ± 0.06 | 63.97 ± 0.16 | |
| 0.00 | 0.00 | 0.73 ± 0.08 | 51.14 ± 0.15 | |
|
| 0.00 | 0.00 | 0.00 | 64,62 ± 0,2 |
| 0.81 ± 0.12 | 0.56 ± 0.1 | 0.45 ± 0.1 | 60.43 ± 0.03 | |
| 0.56 ± 0.13 | 0.55 ± 0.1 | 0.40 ± 0.08 | 51.25 ± 0.08 | |
| 2.75 ± 0.2 | 3.77 ± 0.15 | 2.19 ± 0.12 | 63.21 ± 0.43 | |
| 0.76 ± 0.1 | 0.65 ± 0.02 | 0.00 | 32.33 ± 0.05 | |
| 0.98 ± 0.11 | 0.80 ± 0.05 | 0.43 ± 0.05 | 28.89 ± 0.26 | |
| 0.00 | 0.00 | 0.00 | 52.84 ± 0.02 | |
| 0.44 ± 0.09 | 0.53 ± 0.1 | 0.36 ± 0.07 | 28.69 ± 0.13 | |
| 0.18 ± 0.01 | 0.19 ± 0.02 | 0.21 ± 0.03 | 28.41 ± 0.01 | |
|
| 0.17 ± 0.05 | 0.07 ± 0.001 | 0.00 | 48.95 ± 0.03 |
| 0.66 ± 0.1 | 0.86 ± 0.12 | 0.60 ± 0.01 | 34.27 ± 0.29 | |
| 0.45 ± 0.18 | 0.70 ± 0.03 | 0.59 ± 0.08 | 57.06 ± 0.03 | |
| 0.62 ± 0.11 | 0.47 ± 0.07 | 0.51 ± 0.04 | 56.71 ± 0.12 | |
| 0.0 | 0.27 ± 0.04 | 0.30 ± 0.07 | 29.92 ± 0.02 | |
|
| 0.00 | 0.00 | 0.00 | 43.11 ± 0.01 |
| 1.04 ± 0.11 | 0.60 ± 0.1 | 0.20 ± 0.01 | 61.79 ± 0.39 | |
|
| 0.00 | 0.00 | 0.00 | 32.78 ± 0.04 |
|
| 0.01 ± 0.001 | 0.00 | 0.00 | 54.67 ± 0.12 |
| 0.81 ± 0.14 | 0.55 ± 0.12 | 0.47 ± 0.09 | 51.23 ± 0.36 | |
| 0.72 ± 0.06 | 0.44 ± 0.07 | 0.60 ± 0.04 | 57.22 ± 0.08 | |
| 0.85 ± 0.07 | 0.43 ± 0.09 | 0.75 ± 0.04 | 55.83 ± 0.07 | |
| 0.59 ± 0.01 | 0.54 ± 0.01 | 0.45 ± 0.03 | 42.50 ± 0.04 | |
|
| 0.00 | 0.00 | 0.00 | 52.63 ± 0.06 |
| 0.37 ± 0.11 | 0.21 ± 0.01 | 0.20 ± 0.01 | 30.97 ± 0.12 | |
*Biofilm-forming strains
Fig. 1Classification of biofilm producer bacteria according to Stepanović et al. [8, 15] 0 - nonbiofilm producer; 1 - weak biofilm producer; 2 - moderate biofilm producer; 3 - strong biofilm producer
Autoaggregation ability after 2 and 24 h incubation at 28 °C in PBS (pH 7.3)
| Strains | Autoaggregation (%) | |
|---|---|---|
| 2 h | 24 h | |
|
| 14.82 | 17.25 |
|
| 16.63 | 76.69 |
|
| 0 | 0.63 |
|
| 16.5 | 45.21 |
|
| 9.06 | 67.24 |
|
| 0.61 | 87.46 |
|
| 8.08 | 49.87 |
|
| 0 | 91.51 |
|
| 10.89 | 40.23 |
|
| 17.19 | 36.23 |
|
| 33.95 | 53.25 |
|
| 17.19 | 81.40 |
| 19.61 | 91.23 | |
|
| 0.16 | 4.26 |
|
| 35.19 | 87.63 |
|
| 0 | 0 |
|
| 19.15 | 24.99 |
|
| 31.61 | 51.01 |
|
| 38.44 | 81.31 |
|
| 0 | 2.03 |
|
| 7.21 | 94.12 |
|
| 1.28 | 91.71 |
|
| 2.48 | 5.07 |
|
| 7.38 | 79.25 |
|
| 4.89 | 39.36 |
|
| 0 | 0 |
|
| 0 | 0 |
|
| 0.69 | 42.61 |
|
| 0.91 | 53.38 |
|
| 9.57 | 24.68 |
aBiofilm-forming strains
Fig. 2Light microscope image of autoaggregation after 24 h of incubation in PBS buffer (pH 7.3). A Microbacterium maritypicum B Aeromonas bestiarum. Magnification x500
Fig. 3Motility of selected bacteria on 0.3% agar swim plates after 72 h of incubation. 1. Bacillus horti (diameter of motility halo: 53 mm); 2. Bacillus alcalophilus (diameter of motility halo: 49 mm); 3. Stenotrophomonas maltophilia (diameter of motility halo: 48 mm) 4. CDC group II-H (diameter of motility halos: 44 mm) 5. Variovorax paradoxus (diameter of motility halo: 36 mm) 6. Flavobacterium resinovorum (diameter of motility halo: 38 mm) 7. Pseudomonas fulva (diameter of motility halo: 37 mm) 8. Lactobacillus coryniformis ss coryniformis (diameter of motility halo: 13 mm) 9. Stenotrophomonas rhizophilia (diameter of motility halo: 9 mm) 10. Flavobacterium hydatis (diameter of motility halo: 7 mm) 11. Sphingobacterium multivorum (nonmotile) 12. Paenibacillus azoreducens (nonmotile). Diameters of motility halos were the same after 24 h, 48 h and 72 h of incubation